AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2024
Sep 3, 2024
32853_dirs_2024-09-03_3fa4510f-e190-470e-b25a-31e23a464118.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2024-08-31
Reporting Person: Mackay Sean (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 392168 | Direct |
| Common Stock | 207832 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to buy) | $2.58 | 2034-05-19 | Common Stock (600000) | Direct |
Footnotes
F1: Consists of restricted stock unites ("RSUs"). Each RSU represent the right to receive one share of common stock upon vesting. 1/4 of RSUs will vest on May 20, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
F2: The shares underlying this option will vest as to 25% on May 20, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.